Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2017-2027

Global Vaccine Contract Manufacturing Market Report 2017-2027

Leading Countries, Technologies and Companies

PUBLISHED: 23 February 2017
PAGES: 154
PRODUCT CODE: PHA0172

Clear
WOOCS 2.2.1
SKU: PHA0172 Categories: , ,

The global vaccine contract manufacturing market is expected to grow at a CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. The market is expected to grow at a CAGR of 9.1% from 2016 to 2027. The market is estimated at $816m in 2016, and $2117m in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 74 charts – all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Vaccine Contract Manufacturing Market Report 2017-2027

Report Scope
• Revenue and growth forecasts to 2027 for the global vaccine market and market shares of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines

• Revenue and growth forecasts to 2027 for the global vaccine contract manufacturing market

• Revenue and growth forecasts to 2027 for the leading national markets:
– United States
– Germany
– France
– United Kingdom
– Italy
– Spain
– Japan
– Brazil
– Russia
– China
– India
– Rest of the World

• Revenue and growth forecasts to 2027 for the leading players in the vaccine contract manufacturing market:
– Baxter BioPharma Solutions
– Boehringer Ingelheim
– Catalent
– Charles River Laboratories
– IDT Biologika
– Lonza
– Meridian Life Science
– Sigma Aldrich Fine Chemicals
– Merck
– Synco Bio Partners

• Analysis of what stimulates and restrains the global vaccine contract manufacturing market

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2017-2027: Leading Countries, Technologies and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2017-2027


Latest Pharma news

Visiongain Publishes Pharma Contract Manufacturing Market Report 2020-2030

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry.

10 August 2020

READ

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

READ

Categories

Category